ArticlePLOS global public health2025
Medicalization of female genital mutilation in Egypt: Trends, drivers, and prospects for elimination.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Female genital mutilation (FGM) is a human rights violation that continues to affect over 86% of women and girls in Egypt. While it has declined, the practice is increasingly medicalized posing a significant challenge to abandonment efforts. This study aims to examine FGM medicalization in Egypt by exploring temporal trends, subnational patterns, underlying drivers, and the legal and policy context. We employed a mixed-methods approach, including a quantitative analysis of data from the 1995-2014 Egypt Demographic Health Surveys and the 2021 Egypt Family Health Survey, complemented by existing qualitative data among parents, healthcare providers, NGO program staff, and other stakeholders. Our findings demonstrate a marked decline in FGM prevalence over time and among younger cohorts. However, medicalization has risen sharply, reaching 83% in 2021. We identified three distinct typologies of subnational patterns in FGM prevalence and medicalization: (1) governorates with high FGM prevalence and high medicalization; (2) governorates where FGM persists but medicalization remains lower, and traditional practitioners like dayas - traditional cutters - are still commonly used; and (3) governorates with lower FGM prevalence but high rates of medicalization among those still undergoing the practice. Factors driving the medicalization of FGM in Egypt include persistent cultural beliefs that frame medicalized FGM as a safer option and means of beautification, parental deference to medical providers and a reliance on their "expertise" to determine the necessity for the procedure, limited awareness of FGM health consequences and legal prohibitions, and weak enforcement of penalties. To advance concrete action on medicalized FGM, a multi-level approach is essential-one that strengthens the enforcement of legal bans, integrates FGM into medical curricula and in-service training, and tailors interventions to subnational contexts based on the distinct patterns of FGM prevalence and medicalization across governorates.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.